Synthesis of 2-fluoro-11-hydroxy-N-propylnoraporphine: A potential dopamine D2 agonist

Organic Letters

Volumn 7, Issue 15, 2005, Pages 3239-3242

  Zhang, Ao ^a   Csutoras, Csaba ^a,b   Zong, Rushi ^a   Neumeyer, John L ^a  

^a MCLEAN HOSPITAL   (United States)

^b ESZTERHÁZY KÁROLY UNIVERSITY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

2 FLUORO 11 HYDROXY N PROPYLNORAPORPHINE; 2-FLUORO-11-HYDROXY-N-PROPYLNORAPORPHINE; APORPHINE DERIVATIVE; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; PALLADIUM; THEBAINE;

ANIMAL; ARTICLE; BRAIN; CHEMISTRY; CYTOLOGY; DRUG EFFECT; DRUG POTENTIATION; RAT; SYNTHESIS;

ANIMALS; APORPHINES; BRAIN; DOPAMINE AGONISTS; PALLADIUM; RATS; RECEPTORS, DOPAMINE D2; THEBAINE;

EID: 23044464175     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol051010d     Document Type: Article

References (28)

1. (a) Nomenclature used in this series is as follows: NPA = N-n-propylnorapomorphine which has a catechol moiety; NPa = N-n- propylnoraporphine which has a monohydroxyphenyl moiety.
2. (b) Tyne, H. L.; Parson, J.; Sinott, A.; Fox, S. H.; Steiger, M. J. J. Neurol. 2004, 251, 1370.
3. (c) Neumeyer, J. L.; Baldessarini, R. J.; Booth, R. J. In Burger's Medicinal Chemistry and Drug Discovery, 6th ed.; Abraham, D. J., Ed.; John Wiley & Sons: New York, 2003; p 711.
4. Menon, M. K.; Clark, W. G.; Neumeyer, J. L. Eur. J. Pharm. 1978, 52, 1.
5. (a) Neumeyer, J. L.; Reischig, D.; Arana, G. W.; Campbell, A.; Baldessarini, R. J.; Kula, N. S.; Watling, K. J. Med. Chem. 1983, 26, 516.
6. (b) Neumeyer, J. L.; Arana, G. W.; Law, S. J.; Lamont, J. S.; Kula, N. S.; Baldessarini, R. J. J. Med. Chem. 1981, 24, 1440.
7. (c) Neumeyer, J. L.; Arana, G. W.; Ram, V. J.; Kula, N. S.; Baldessarini, R. J. J. Med. Chem. 1982, 25, 990.
8. (d) Gao, Y.; Baldessarini, R. J.; Kula, N. S.; Neumeyer, J. L. J. Med. Chem. 1990, 33, 1800.
9. (e) Berenyi, S.; Csutoras, Cs.; Makleit, S.; Auth, F.; Laszlovszky, I.; Kiss, B.; Karpati, E.; Low, M. Med. Chem. Res. 1997, 509.
10. (f) Auth, F.; Laszlovszky, I.; Kiss, B.; Karpati, E.; Berenyi, S.; Csutoras, Cs.; Makleit, S.; Low, M. Differential effects of 2-(ethylthio)- apomorphine enantiomers on striatal dopamine overflow in vivo Neurochemistry; Teelken, A.; Korf, J., Eds.; Plenum Press: New York, 1997; p 215.
11. (g) Ramsby, S.; Neumeyer, J. L.; Grigoriadis, D.; Seeman, P. J. Med. Chem. 1989, 32, 1198.
12. (h) Neumeyer, J. L.; Gao, Y.; Kula, N. S.; Baldessarini, R. J. J. Med. Chem. 1990, 33, 3122.
13. (i) Csutoras, Cs.; Zhang, A.; Zhang, K.; Kula, N. S.; Baldessarini, R. J.; Neumeyer, J. L. Bioorg. Med. Chem. 2004, 3553.
14. Neumeyer, J. L.; Law, S. J.; Meldrum, B.; Anlezark, G.; Watling, K. J. J. Med. Chem. 1981, 24, 898.
15. (a) Ram, V. J.; Neumeyer, J. L. J. Org. Chem. 1982, 47, 4372.
16. (b) Derrick, I.; Neilan, C. L.; Andes, J.; Husbands, S. M.; Woods, J. H.; Traynor, J. R.; Lewis, J. W. J. Med. Chem. 2000, 44, 3348.
17. Berenyi, S.; Makleit, S.; Rantal, F. Acta Chim. Hung. 1985, 120, 201.
18. Simon, Cs.; Hosztafi, S.; Makleit, S.; Berenyi, S. Synth. Commun. 1991, 21, 2309.
19. (a) Berenyi, S.; Hosztafi, S.; Makleit, S. J. Chem. Soc., Perkin Trans. 1, 1992, 2693.
20. (b) Berenyi, S.; Czirjak, M.; Makleit, S. J. Chem. Soc., Perkin Trans, 1 1993, 2137.
21. Hauser, F. M.; Chen, T.; Carroll, F. I. J. Med. Chem. 1974, 17, 1117.
22. Rice, K. C. J. Med. Chem. 1977, 20, 164.
23. Iijima, I.; Minamikawa, J.; Jacobson, A. E.; Brossi, A.; Rice, K. C. J. Med. Chem. 1978, 21, 398.
24. Sargent, L. J.; Schwartzman, L. H.; Small, L. F. J. Org. Chem. 1958, 23, 1247.
25. Weiss, U.; Daum, S. J. J. Med. Chem. 1965, 8 (1), 123.
26. Hedberg, M. H.; Johansson, A. M.; Nordvall, G.; Yliniemela, A.; Li, H. B.; Martin, A. R.; Hjorth, S.; Unelius, L.; Sundell, S.; Hacksell, U. J. Med. Chem. 1995, 38, 647.
27. Makleit, S.; Radics, L.; Bognar, R.; Mile, T. Acta Chim. Hung. 1972, 74, 111.
28. 20FNO·HCl)CalCd: C, 68.36; H, 6.34; N, 4.20. Found: C, 68.31; H, 6.38; N, 4.15.